吉林中医药2025，Vol.45Issue(4)：378-382,5.DOI:10.13463/j.cnki.jlzyy.2025.04.002
越鞠丸化裁防治肺癌应用经验探析
Application experience of modified Yueju Wan in prevention and treatment of lung cancer
摘要
Abstract
Lung cancer is the malignant tumor with the highest morbidity and mortality in China.Deficiency of middle qi leads to a qi movement stagnation in its ascending and descending cycle,which in turn results in body fluids depletion and stagnant blood blockade,heat generation and phlegm coagulation.And all the above pathogenic factors fight and intertwine with each other to transform into cancer toxin.Therefore,"deficiency"and"stagnation"feature the core etiology and pathogenesis in the occurrence and development of lung cancer.Although Yueju Wan is primarily used to reinforce middle jiao,it can also be used to regulate and activate qi movement,resolve the stagnation of qi,blood,phlegm,fire,dampness and food,which happens to be in line with the pathogenesis of cancer toxin.In our clinical practice,Yueju Wan is applied as the main prescription for the treatment of lung cancer in different stages to achieve good therapeutic effects.In the precancerous stage,it is mainly used to relieve stagnation and regulate qi to prevent the transmission of cancer toxin.After lung cancer surgery,it is mainly used to relieve stagnation and detoxify to remove the postoperative residual toxin.In the recovery phase,Yueju Wan is mainly used to resolve depression and strengthen the body to prevent the disease recurrence.The application of Yueju Wan in the treatment of lung cancer embodies the characteristics of holistic concept,treating different diseases with the same method,and a preventive treatment of diseases in traditional Chinese medicine.关键词
越鞠丸/肺癌/中气理论/异病同治/治未病Key words
Yueju Wan/lung cancer/middle qi theory/treating different diseases with the same method/分类
医药卫生引用本文复制引用
马苏苏,任晓玲,高劲,宋英,李柏慧,郑红刚..越鞠丸化裁防治肺癌应用经验探析[J].吉林中医药,2025,45(4):378-382,5.基金项目
国家自然科学基金项目(82174463) （82174463）
中央高水平中医医院临床研究和成果转化能力提升项目-传承名老中医药专家学术经验专项(HLCMHPP2023007) （HLCMHPP2023007）
